BioArctic hires Anders Martin-Löf as new CFO
Stockholm, February 28, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has recruited Anders Martin-Löf as its new CFO. Anders Martin-Löf brings broad experience from similar roles at companies such as Oncopeptides, Wilson Therapeutics, RaySearch and most recently at A3P Biomedical. Current CFO Jan Mattsson will remain in his role until Anders Martin-Löf takes up his position and will then move to a newly established role as VP Finance.“Jan joined BioArctic in early 2017 to assist in the important work of listing the company and has been instrumental